{"id":"NCT04258839","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","briefTitle":"Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148","officialTitle":"A Phase 3, Multicenter, Open Label Trial to Evaluate the Long-term Safety and Tolerability of Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-01-23","primaryCompletion":"2023-03-16","completion":"2023-03-16","firstPosted":"2020-02-06","resultsPosted":"2024-05-30","lastUpdate":"2024-05-30"},"enrollment":95,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Irritability Associated With Autism Spectrum Disorder"],"interventions":[{"type":"DRUG","name":"Brexpiprazole","otherNames":["OPC-34712","LuAF41156"]}],"arms":[{"label":"Brexpiprazole","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the long-term safety and tolerability of brexpiprazole in children and adolescent participants, aged 5 to 17, with irritability associated with autism spectrum disorder.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs) Graded By Severity, Serious TEAEs and Trial Discontinuation Due to TEAEs","timeFrame":"From the first dose of study drug (in current study) up to 21 days after the last dose of study drug (up to approximately 29 weeks)","effectByArm":[{"arm":"Prior Brexpiprazole","deltaMin":23,"sd":null},{"arm":"Prior Placebo","deltaMin":24,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":28,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":49},"commonTop":["Weight Increased","Increased Appetite","Somnolence","Viral Influenza","Gastroenteritis"]}}